BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25799787)

  • 1. [Molecular aspects of corneal neovascularization].
    Krawczyk P; Ambroziak AM; Szaflik JP
    Klin Oczna; 2014; 116(3):210-4. PubMed ID: 25799787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent drug therapies for corneal neovascularization.
    Liu X; Wang S; Wang X; Liang J; Zhang Y
    Chem Biol Drug Des; 2017 Nov; 90(5):653-664. PubMed ID: 28489275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-1 is regulated by miR-204 and contributes to corneal neovascularization in KLEIP-deficient mice.
    Kather JN; Friedrich J; Woik N; Sticht C; Gretz N; Hammes HP; Kroll J
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4295-303. PubMed ID: 24917145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse models of corneal neovascularization: new perspectives for angiogenesis research.
    Kather JN; Kroll J
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(11):7637-51. PubMed ID: 25425566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-based antiangiogenic applications for corneal neovascularization.
    Liu S; Romano V; Steger B; Kaye SB; Hamill KJ; Willoughby CE
    Surv Ophthalmol; 2018; 63(2):193-213. PubMed ID: 29080632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of topical infliximab on corneal neovascularization in rabbits.
    Kim JW; Chung SK
    Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
    Hosseini H; Nejabat M
    Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel aspects of corneal angiogenic and lymphangiogenic privilege.
    Ellenberg D; Azar DT; Hallak JA; Tobaigy F; Han KY; Jain S; Zhou Z; Chang JH
    Prog Retin Eye Res; 2010 May; 29(3):208-48. PubMed ID: 20100589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 agonist regulates angiogenesis and inhibits corneal neovascularization.
    Wu J; Cui H; Dick AD; Liu L
    Am J Pathol; 2014 Jun; 184(6):1900-10. PubMed ID: 24726642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
    Wang Y; Yin H; Chen P; Xie L; Wang Y
    Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F; Zhang MC; Zhu Y
    Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.
    Sivak JM; Ostriker AC; Woolfenden A; Demirs J; Cepeda R; Long D; Anderson K; Jaffee B
    J Biol Chem; 2011 Dec; 286(52):44965-75. PubMed ID: 22072717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging techniques to treat corneal neovascularisation.
    Menzel-Severing J
    Eye (Lond); 2012 Jan; 26(1):2-12. PubMed ID: 21979862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ablation of CD36 induces age-related corneal neovascularization.
    Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
    Cornea; 2008 Oct; 27(9):1037-41. PubMed ID: 18812768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of curcumin on corneal neovascularization in rabbit eyes.
    Kim JS; Choi JS; Chung SK
    Curr Eye Res; 2010 Apr; 35(4):274-80. PubMed ID: 20373893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L; Fan Y; Wang F; Gu Q; Xu X
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesis.
    Celec P; Yonemitsu Y
    Biomed Pharmacother; 2008; 62(6):349-51. PubMed ID: 18406102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization.
    Bai Y; Wang W; Sun G; Zhang M; Dong J
    Cell Prolif; 2016 Dec; 49(6):751-762. PubMed ID: 27625050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.